They reported that MBZ significantly inhibited tumor growth in cisplatin resistant HGSOC PDXs regardless of p53 status, suggesting that MBZ could be an effective therapy for platinum resistant ovarian cancer. The gene discussed is TP53; the disease is ovarian cancer.